新医学
新醫學
신의학
NEW CHINESE MEDICINE
2014年
12期
824-827
,共4页
七叶皂苷钠%带状疱疹%后遗神经痛
七葉皂苷鈉%帶狀皰疹%後遺神經痛
칠협조감납%대상포진%후유신경통
Sodium aescinate%Herpes zoster%Postherpetic neuralgia
目的:探讨七叶皂苷钠联合伐昔洛韦治疗中老年带状疱疹的疗效。方法120例患者均为门诊或住院部中老年带状疱疹患者,将其随机分为A、B、C三组,每组40例。其中,A组采用基础治疗方案,即口服伐昔洛韦(每次0.3 g,每日2次)和甲钴胺(每次0.5 mg,每日3次),外加莫匹罗星软膏每日2次外搽;B组和C组采用与A组相同治疗方案的同时,分别加用地塞米松(5 mg/d)或七叶皂苷钠(20 mg/d)静脉滴注治疗,3组疗程均为9 d。结果治疗后B组和C组疗效显著高于A组,比较差异有统计学意义(qA-B =3.72,P<0.05和qA-C =3.51,P<0.05),而B组和C组间疗效比较差异无统计学意义(qB-C =1.29,P>0.05)。治疗后B组和C组患者的疼痛缓解时间、止痛时间、结痂时间、VAS评分明显低于A组(P均<0.01),C组疼痛缓解时间低于B组,而B、C两组的止痛时间、结痂时间比较差异无统计学意义(P>0.05)。C组患者疱疹后遗神经痛(PHN )发生率显著低于A组,比较差异有统计学意义(χ2=4.30,P<0.017)。结论对中老年带状疱疹患者早期给予七叶皂苷钠治疗,不但可收到较好的疗效,而且可以减少PHN的发生,同时又能避免应用糖皮质激素可能产生的不良反应。
目的:探討七葉皂苷鈉聯閤伐昔洛韋治療中老年帶狀皰疹的療效。方法120例患者均為門診或住院部中老年帶狀皰疹患者,將其隨機分為A、B、C三組,每組40例。其中,A組採用基礎治療方案,即口服伐昔洛韋(每次0.3 g,每日2次)和甲鈷胺(每次0.5 mg,每日3次),外加莫匹囉星軟膏每日2次外搽;B組和C組採用與A組相同治療方案的同時,分彆加用地塞米鬆(5 mg/d)或七葉皂苷鈉(20 mg/d)靜脈滴註治療,3組療程均為9 d。結果治療後B組和C組療效顯著高于A組,比較差異有統計學意義(qA-B =3.72,P<0.05和qA-C =3.51,P<0.05),而B組和C組間療效比較差異無統計學意義(qB-C =1.29,P>0.05)。治療後B組和C組患者的疼痛緩解時間、止痛時間、結痂時間、VAS評分明顯低于A組(P均<0.01),C組疼痛緩解時間低于B組,而B、C兩組的止痛時間、結痂時間比較差異無統計學意義(P>0.05)。C組患者皰疹後遺神經痛(PHN )髮生率顯著低于A組,比較差異有統計學意義(χ2=4.30,P<0.017)。結論對中老年帶狀皰疹患者早期給予七葉皂苷鈉治療,不但可收到較好的療效,而且可以減少PHN的髮生,同時又能避免應用糖皮質激素可能產生的不良反應。
목적:탐토칠협조감납연합벌석락위치료중노년대상포진적료효。방법120례환자균위문진혹주원부중노년대상포진환자,장기수궤분위A、B、C삼조,매조40례。기중,A조채용기출치료방안,즉구복벌석락위(매차0.3 g,매일2차)화갑고알(매차0.5 mg,매일3차),외가막필라성연고매일2차외차;B조화C조채용여A조상동치료방안적동시,분별가용지새미송(5 mg/d)혹칠협조감납(20 mg/d)정맥적주치료,3조료정균위9 d。결과치료후B조화C조료효현저고우A조,비교차이유통계학의의(qA-B =3.72,P<0.05화qA-C =3.51,P<0.05),이B조화C조간료효비교차이무통계학의의(qB-C =1.29,P>0.05)。치료후B조화C조환자적동통완해시간、지통시간、결가시간、VAS평분명현저우A조(P균<0.01),C조동통완해시간저우B조,이B、C량조적지통시간、결가시간비교차이무통계학의의(P>0.05)。C조환자포진후유신경통(PHN )발생솔현저저우A조,비교차이유통계학의의(χ2=4.30,P<0.017)。결론대중노년대상포진환자조기급여칠협조감납치료,불단가수도교호적료효,이차가이감소PHN적발생,동시우능피면응용당피질격소가능산생적불량반응。
Objective To investigate the clinical efficacy of sodium aescinate in combination with va-laciclovir in the treatment of herpes zoster in middle-aged and elderly patients. Method A total of 120 cases of herpes zoster admitted to the in-patients and out-patients in hospital were randomly divided into groups A,B and C (n=40 for each group). Patients in group A received basic treatment including oral intake of valaciclov-ir (0. 3 g,twice a day),orally mecobalamine (0. 5 mg,three times a day)and external topical use of mupiro-cin ointment twice a day. Patients in groups B and C were treated with dexamethasone 5 mg/d i. v. drip or so-dium aescinate 20 mg/d i. v. drip,besides the basic treatment delivered in group A. The course of treatment endured for 9 days. Results The therapeutic effects in groups B and C were significantly higher than that in group A (qA-B =3. 72,P<0. 05 and qA-C =3. 51,P<0. 05),whereas no significant difference was found be-tween groups B and C (qB-C =1. 29,P>0. 05). The time of pain relief,time of analgesia,time of scarring and VAS in both groups B and C were remarkably shorter and lower than those in group A (all P<0. 01). Mo-reover,the time of pain relief in group C was shorter than that in group B whereas no significant difference was found between groups B and C regarding time of scarring and time of analgesia (P>0. 05 ). Finally,the inci-dence of postherpetic neuralgia (PHN)in group C was significantly lower than that in group A (χ2 =4. 30,P<0. 017). Conclusions The application of sodium aescinate is efficacious in the treatment of early-stage her-pes zoster in middle-aged and elderly patients. Moreover,it reduces the incidence of PHN and prevents the oc-currence of adverse events induced by use of glucocorticoid.